SynthesisPloS one2013

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.

Xiaofeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.